Griffin MD - Search Results

1

Interspecies Incompatibilities Limit the Immunomodulatory Effect of Human Mesenchymal Stromal Cells in the Rat.

Lohan P, Treacy O, Morcos M, Donohoe E, O'donoghue Y, Ryan AE, Elliman SJ, Ritter T, Griffin MD. Lohan P, et al. Among authors: griffin md. Stem Cells. 2018 Aug;36(8):1210-1215. doi: 10.1002/stem.2840. Epub 2018 May 16. Stem Cells. 2018. PMID: 29726063

2

Gene therapy in transplantation: Toward clinical trials.

Ritter T, Nosov M, Griffin MD. Ritter T, et al. Among authors: griffin md. Curr Opin Mol Ther. 2009 Oct;11(5):504-12. Curr Opin Mol Ther. 2009. PMID: 19806498 Review.

3

Immunological aspects of allogeneic mesenchymal stem cell therapies.

Griffin MD, Ritter T, Mahon BP. Griffin MD, et al. Hum Gene Ther. 2010 Dec;21(12):1641-55. doi: 10.1089/hum.2010.156. Hum Gene Ther. 2010. PMID: 20718666 Review.

4

Mesenchymal stem cell effects on T-cell effector pathways.

Duffy MM, Ritter T, Ceredig R, Griffin MD. Duffy MM, et al. Among authors: griffin md. Stem Cell Res Ther. 2011 Aug 11;2(4):34. doi: 10.1186/scrt75. Stem Cell Res Ther. 2011. PMID: 21861858 Free PMC article. Review.

5

Anti-donor immune responses elicited by allogeneic mesenchymal stem cells: what have we learned so far?

Griffin MD, Ryan AE, Alagesan S, Lohan P, Treacy O, Ritter T. Griffin MD, et al. Immunol Cell Biol. 2013 Jan;91(1):40-51. doi: 10.1038/icb.2012.67. Epub 2012 Dec 4. Immunol Cell Biol. 2013. PMID: 23207278 Review.

6

Concise review: adult mesenchymal stromal cell therapy for inflammatory diseases: how well are we joining the dots?

Griffin MD, Elliman SJ, Cahill E, English K, Ceredig R, Ritter T. Griffin MD, et al. Stem Cells. 2013 Oct;31(10):2033-41. doi: 10.1002/stem.1452. Stem Cells. 2013. PMID: 23766124 Review.

7

Chondrogenic differentiation increases antidonor immune response to allogeneic mesenchymal stem cell transplantation.

Ryan AE, Lohan P, O'Flynn L, Treacy O, Chen X, Coleman C, Shaw G, Murphy M, Barry F, Griffin MD, Ritter T. Ryan AE, et al. Among authors: griffin md. Mol Ther. 2014 Mar;22(3):655-667. doi: 10.1038/mt.2013.261. Epub 2013 Nov 1. Mol Ther. 2014. PMID: 24184966 Free PMC article.

8

Autologous and allogeneic mesenchymal stem cells in organ transplantation: what do we know about their safety and efficacy?

Alagesan S, Griffin MD. Alagesan S, et al. Among authors: griffin md. Curr Opin Organ Transplant. 2014 Feb;19(1):65-72. doi: 10.1097/MOT.0000000000000043. Curr Opin Organ Transplant. 2014. PMID: 24370985 Review.

9

The influence of hypoxia on the differentiation capacities and immunosuppressive properties of clonal mouse mesenchymal stromal cell lines.

Prado-Lòpez S, Duffy MM, Baustian C, Alagesan S, Hanley SA, Stocca A, Griffin MD, Ceredig R. Prado-Lòpez S, et al. Among authors: griffin md. Immunol Cell Biol. 2014 Aug;92(7):612-23. doi: 10.1038/icb.2014.30. Epub 2014 Apr 29. Immunol Cell Biol. 2014. PMID: 24777310

10

Changes in immunological profile of allogeneic mesenchymal stem cells after differentiation: should we be concerned?

Lohan P, Coleman CM, Murphy JM, Griffin MD, Ritter T, Ryan AE. Lohan P, et al. Among authors: griffin md. Stem Cell Res Ther. 2014 Aug 19;5(4):99. doi: 10.1186/scrt488. Stem Cell Res Ther. 2014. PMID: 25158057 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

311 results

Search Page

Filters